Becker's Healthcare April 12, 2023
Rochester, Minn.-based Mayo Clinic is partnering with biotech company Naveris to launch a clinical trial of the company’s precision medicine blood test for tumor tissue DNA, NavDx.
Naveris aims for NavDx to improve treatment selection in patients with HPV-based head and neck cancers. NavDx analyzes tumor-derived DNA from patients’ blood samples to monitor for residual molecular disease, according to an...